A new trading day began on Tuesday, with Vincerx Pharma Inc (NASDAQ: VINC) stock price down -3.35% from the previous day of trading, before settling in for the closing price of $0.36. VINC’s price has ranged from $0.33 to $9.37 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 57.67%. With a float of $22.95 million, this company’s outstanding shares have now reached $30.88 million.
Let’s look at the performance matrix of the company that is accounted for 42 employees. In terms of profitability, gross margin is 20.4%, operating margin of -2335.92%, and the pretax margin is -2199.54%.
Vincerx Pharma Inc (VINC) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Vincerx Pharma Inc is 25.69%, while institutional ownership is 34.66%.
Vincerx Pharma Inc (VINC) Performance Highlights and Predictions
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.46 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 57.67% per share during the next fiscal year.
Vincerx Pharma Inc (NASDAQ: VINC) Trading Performance Indicators
Here are Vincerx Pharma Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.31, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.67 in one year’s time.
Technical Analysis of Vincerx Pharma Inc (VINC)
Vincerx Pharma Inc (NASDAQ: VINC) saw its 5-day average volume 0.34 million, a negative change from its year-to-date volume of 0.7 million. As of the previous 9 days, the stock’s Stochastic %D was 35.97%. Additionally, its Average True Range was 0.04.
During the past 100 days, Vincerx Pharma Inc’s (VINC) raw stochastic average was set at 4.83%, which indicates a significant decrease from 28.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.21% in the past 14 days, which was lower than the 112.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5807, while its 200-day Moving Average is $1.5476. Nevertheless, the first resistance level for the watch stands at $0.3639 in the near term. At $0.3819, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.4038. If the price goes on to break the first support level at $0.3240, it is likely to go to the next support level at $0.3021. Assuming the price breaks the second support level, the third support level stands at $0.2841.
Vincerx Pharma Inc (NASDAQ: VINC) Key Stats
With a market capitalization of 10.69 million, the company has a total of 29,672K Shares Outstanding. Currently, annual sales are 0 K while annual income is -40,160 K. The company’s previous quarter sales were 0 K while its latest quarter income was -1,810 K.
